Value of phase-shift gradient-echo MR imaging in the differentiation of pelvic lesions with high signal intensity at T1-weighted imaging
other
OA: closed
public-domain-us
AI-generated summary
Phase-shift gradient-echo MR imaging better differentiated hemorrhagic tumors and teratomas with high T1 signal intensity than conventional T1- and T2-weighted imaging.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PURPOSE: To assess the value of phase-shift gradient-echo magnetic resonance (MR) imaging with the fast low-angle shot (FLASH) technique in the differentiation of hemorrhagic tumors and teratomas.
MATERIALS AND METHODS: T1- and T2-weighted spin-echo imaging and phase-shift MR imaging were performed in 60 patients. On T1-weighted images, the signal intensity of lesions was compared with that of intraperitoneal fat. Findings at MR imaging were compared with the surgical findings. The diagnostic performance of each pulse sequence was analyzed with receiver operating characteristic curves.
RESULTS: Sixty high-signal-intensity lesions were identified in 45 patients at T1-weighted imaging. Hemorrhagic lesions and teratomas had similar signal intensities on both T1- and T2-weighted images. Lesions were detected more decisively with FLASH imaging than with T1- and T2-weighted imaging.
CONCLUSIONS: Phase-shift gradient-echo imaging is a readily available method for the differential diagnosis of lesions with high signal intensity at T1-weighted MR imaging.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- pubmed
- last seen: 2026-05-13T22:11:24.284338+00:00
- unpaywall
- last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine